Skip to main content
$73.04 $0.29 (0.4%)

08:00 PM EDT on 09/24/20

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 3 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Current Price $73.04 Mkt Cap $4.2B
Open $0.00 P/E Ratio 0.00
Prev. Close $72.75 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 229,721
52-Wk Range $32.95 - $74.47 Avg. Daily Vol. 543,188

Caps

How do you think NASDAQ:ARNA will perform against the market?

Add Stock to CAPS Watchlist

All Players

757 Outperform
67 Underperform
 

All-Star Players

89 Outperform
15 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ARNA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

JaxPicks (56.25)
Submitted January 17, 2020

Several unique therapies showing promise in trials for large unaddressed diseases.

opgenortht (< 20)
Submitted April 22, 2010

obesity market for drugs without significant sustained weight loss - greater than 10% - is impossible to penetrate without gigantic consumer-directed, expensive, advertising....remember 10% for a 250lb person is 25lb bringing their new weight to… More

NASDAQ:ARNA VS S&P 500 (SPY)

Fools bullish on NASDAQ:ARNA are also bullish on:

Fools bearish on NASDAQ:ARNA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ARNA.

Recs

0
Member Avatar FVelociraptor (99.66) Submitted: 1/28/2020 11:36:09 AM : Underperform Start Price: $43.95 NASDAQ:ARNA Score: -66.94

https://velociraptor.cc

Recs

1
Member Avatar JaxPicks (56.25) Submitted: 1/17/2020 9:27:54 AM : Outperform Start Price: $46.55 NASDAQ:ARNA Score: +59.03

Several unique therapies showing promise in trials for large unaddressed diseases.

Recs

1
Member Avatar healthcarevalue (76.26) Submitted: 12/27/2019 12:53:08 PM : Outperform Start Price: $46.10 NASDAQ:ARNA Score: +58.05

Trailing price earnings ratio 4.29. Debt equity ratio of 0.04. Return on invested capital of 60.54 percent.

Leaderboard

Find the members with the highest scoring picks in ARNA.

Score Leader

bluemoth

bluemoth (< 20) Score: +757.14

The Score Leader is the player with the highest score across all their picks in ARNA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. farhangp 58.66 6/23/2017 Outperform 5Y $14.98 +386.66% +32.96% +353.70 0 Comment
neallp31 21.88 11/18/2016 Outperform 5Y $15.40 +373.31% +48.12% +325.20 0 Comment
whitebonez 34.95 4/5/2011 Outperform 5Y $13.35 +445.99% +142.36% +303.63 0 Comment
Geode59 < 20 11/18/2010 Outperform 5Y $12.75 +471.69% +169.38% +302.30 0 Comment
palinkrk 20.60 4/8/2011 Outperform 1Y $13.72 +431.42% +142.96% +288.46 0 Comment
rruz < 20 10/30/2015 Outperform 5Y $16.50 +341.76% +55.02% +286.74 0 Comment
MaBrandao 41.58 3/21/2016 Outperform 1Y $16.40 +344.45% +58.52% +285.93 0 Comment
WiseWillyAgain 53.93 7/5/2017 Outperform 5Y $17.46 +317.47% +33.33% +284.14 1 Comment
EricMendelsohn < 20 6/6/2011 Outperform 1Y $13.80 +428.19% +148.67% +279.51 0 Comment
pastordisaster < 20 11/17/2010 Outperform 5Y $13.20 +452.20% +173.25% +278.95 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARNA.